Thanks bottle2
I’ve done my research
New cohesive BOD with global experience
New management team with global sales experience
New sales force with experience in the field
Cashed up, zero debt and growing revenue by impressive double digits
Exceeded sales forecast
What isn’t lost on me in the below is the reference to “ first 12 months ” so this really has been a reset of the whole business from within
- Quarterly sales of $5.1M taking revenue for first 12 months to $22.0M up ~58% on the prior corresponding period (PCP) and exceeding annual forecast expectations by ~$1.0M.
I’m very much looking forward to what I believe will be an exciting few years ahead for Admedus, and in turn we shareholders
My thoughts on AHZ, page-119
-
- There are more pages in this discussion • 123 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.10 |
Change
-0.810(8.17%) |
Mkt cap ! $192.3M | |||
| Open | High | Low | Value | Volume |
| $9.50 | $9.77 | $9.01 | $212.2K | 22.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 298 | $9.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.85 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |